MeetMe Inc (NASDAQ:MEET), the public market leader for social discovery, has released Icebreakers, a new feature for the MeetMe iPhone app that makes it easier for users to start a chat. “Icebreakers solves the problem of the empty chat screen,” said Geoff Cook, CEO of MeetMe. “Rather than starting conversations with a generic ‘Hi’ or ‘What’s up,’ or possibly not starting them at all for lack of knowing what to say, Icebreakers makes sending an engaging first chat as simple as one tap. We believe it has the potential to increase both the number and quality of chats, leading to more replies and ultimately higher user engagement.” MeetMe Inc (NASDAQ:MEET) stock performance was -8.29% in last session and finished the day at $1.88. Traded volume was 1,932,766 shares in the last session and the average volume of the stock remained 1.25 million shares. The beta of the stock remained 2.50. MeetMe Inc (NASDAQ:MEET) insider ownership is 0.60%.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)’s Director Michael E. Porter bought 15,000 shares of the stock on the open market in a transaction dated Friday, May 16th. The stock was purchased at an average cost of $6.49 per share, for a total transaction of $97,350.00. Following the acquisition, the director now directly owns 535,865 shares of the company’s stock, valued at approximately $3,477,764. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) rose 1.64% to $6.80 yesterday on volume of 2,149,060 shares. The intra-day range of the stock was $6.33 – 6.88. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) has a market capitalization of $703.16 million.

Needham & Company LLC upgraded shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) from a buy rating to a strong-buy rating in a report released on Thursday, TheFlyOnTheWall.com reports. Needham & Company LLC currently has $10.00 price objective on the stock, up from their previous price objective of $6.30. Pernix Therapeutics Holdings Inc (NASDAQ:PTX)’s stock on May 16, 2014 reported a decrease of -1.56% to the closing price of $6.33. Its fifty two weeks range is $1.68 – 6.66. The total market capitalization recorded $239.10 million. The overall volume in the last trading session was 2,389,980 shares. In its share capital, Pernix Therapeutics Holdings Inc (NASDAQ:PTX) has 37.76 million outstanding shares.

Dillard’s, Inc. (NYSE:DDS) reported first quarter EPS of $2.56 after the close Thursday, up from $2.50 in the prior year period. The consensus estimate was for EPS of $2.41. Dillard’s gapped up sharply Friday and climbed for the majority of the morning. The stock ended the session higher by 14.40 at $111.00, with volume at nearly a 3-month high. Dillard’s surged to a new high for the year On Friday, shares of Dillard’s, Inc. (NYSE:DDS) advanced 14.91% to close the day at $111.00. Company return on investment (ROI) is 13.30% and its monthly performance is recorded as 20.60%. Dillard’s, Inc. (NYSE:DDS) quarterly revenue growth is 23.83%.

TD Securities downgraded Just Energy Group (NYSE: JE) from Buy to Reduce with a price target of C$5 (from C$10). Analyst Damir Gunja said he expects a dividend cut at some point. On Friday, shares of Just Energy Group, Inc. Ordinary Shares (Canada) (NYSE:JE) dropped -16.62% to close the day at $6.02. Company monthly performance is recorded as -22.82%. Just Energy Group, Inc. Ordinary Shares (Canada) (NYSE:JE) quarterly revenue growth is -18.76%.